Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Semaglutide has started doing some of its work, which is slowing down how quickly food leaves your stomach
Meanwhile, dual and triple agonists targeting receptors beyond GLP-1R are continuously developed in preclinical models
Clin Chem Lab Med (2005) 43:71520
Reduces cardiovascular risk factors Excess weight, especially if it has been carried for a long time, can greatly increase your risk of heart disease
We expect to see more pack trade-offs in potato chips, soft drinks and cold cereal but we also see outsized pack trade-offs in coffee and granola, which implies two emerging trends in the GLP-1 population: a general decrease in snacking, even for snacks usually considered healthy, and overall collateral damage that is spreading to categories that should not be greatly affected by GLP-1 status. In addition to their impact on the retail food and beverage market, oral GLP-1 medications are expected to account for 20% of total GLP-1 drug sales by 2031, with a pill market that is estimated to grow from $3.2 billion in 2025 to $34.3 billion in 2031, according to GlobalData.
Nikolaidis et al
